Home » Topics » Conferences

Conferences
RSS

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

Research at Pfizer leads to potent CysLT1 antagonist

April 2, 1998

Merck & Co. identifies orally active, short-acting GH secretatogue

April 2, 1998

Liposomal telomerase antisense oligonucleotide effective alone and in combination

April 2, 1998

Protein farnesyltransferase inhibitor advanced to clinical trials by Schering-Plough

April 2, 1998

Preclinical data indicates efficacy of AltaRex's approach to cancer immunotherapy

April 2, 1998

Cardioprotective effects of new Lederle compound assessed

April 2, 1998

Dramatic anticancer activity observed with FGN-1 in animal models

April 2, 1998

Nefiracetam: a potential treatment for PCP addiction?

April 2, 1998

TAPET efficacy reported at AACR meeting

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...